Form 4: Encompass Health Director Receives Dividend-Linked RSUs

Director Joan E. Herman acquired 85 restricted stock units as part of a dividend reinvestment program.

Summary

• Director Joan E. Herman was granted 85 restricted stock units (RSUs) on April 15, 2026.
• The acquisition resulted from the company's dividend payment of $0.19 per share.
• The total number of shares beneficially owned by the director following this transaction is 47,924.
• The transaction reflects the automatic crediting of RSUs based on dividend reinvestment formulas.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation.

Positives

• Demonstrates alignment between director interests and shareholder dividend returns.
• Reflects ongoing participation in the company's equity incentive program.

Negatives

• None identified; this is a routine administrative transaction.

Risks

• None identified; this is a routine administrative transaction.

Future Outlook

Not applicable as this is a routine disclosure of director equity holdings.

Industry Context

StockSavvy.ai notes that dividend reinvestment for directors is a standard corporate governance practice designed to maintain long-term alignment between board members and shareholders in the healthcare services sector.

Comparison to Industry Standards

• The transaction follows standard industry practices for non-employee director compensation and dividend treatment.
• Consistent with governance policies at peer healthcare providers such as HCA Healthcare or Universal Health Services.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity adjustment.

Next Steps

• No future actions required by the reporting person.

Key Dates

Keywords

Encompass Health, EHC, Form 4, Insider Trading, Dividend Reinvestment, Director Ownership